150 related articles for article (PubMed ID: 20501756)
1. Spatial patterns of localized-stage prostate cancer incidence among white and black men in the southeastern United States, 1999-2001.
Altekruse SF; Huang L; Cucinelli JE; McNeel TS; Wells KM; Oliver MN
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1460-7. PubMed ID: 20501756
[TBL] [Abstract][Full Text] [Related]
2. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut.
Polednak AP; Flannery JT
Cancer; 1992 Oct; 70(8):2152-8. PubMed ID: 1394045
[TBL] [Abstract][Full Text] [Related]
3. Geographical, temporal and racial disparities in late-stage prostate cancer incidence across Florida: a multiscale joinpoint regression analysis.
Goovaerts P; Xiao H
Int J Health Geogr; 2011 Dec; 10():63. PubMed ID: 22142274
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
Steele CB; Li J; Huang B; Weir HK
Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5160-5177. PubMed ID: 29205313
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States).
Danley KL; Richardson JL; Bernstein L; Langholz B; Ross RK
Cancer Causes Control; 1995 Nov; 6(6):492-8. PubMed ID: 8580296
[TBL] [Abstract][Full Text] [Related]
6. Race and the likelihood of localized prostate cancer at diagnosis among men in 4 southeastern states.
Oliver MN; Stukenborg GJ
J Natl Med Assoc; 2009 Aug; 101(8):750-7. PubMed ID: 19715036
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer treatment patterns among racial/ethnic groups in Florida.
Xiao H; Warrick C; Huang Y
J Natl Med Assoc; 2009 Sep; 101(9):936-43. PubMed ID: 19806852
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
9. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008.
Cook MB; Rosenberg PS; McCarty FA; Wu M; King J; Eheman C; Anderson WF
Prostate; 2015 May; 75(7):758-63. PubMed ID: 25619191
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer incidence and mortality rates among white and black men.
Merrill RM; Brawley OW
Epidemiology; 1997 Mar; 8(2):126-31. PubMed ID: 9229202
[TBL] [Abstract][Full Text] [Related]
11. Dietary factors and risks for prostate cancer among blacks and whites in the United States.
Hayes RB; Ziegler RG; Gridley G; Swanson C; Greenberg RS; Swanson GM; Schoenberg JB; Silverman DT; Brown LM; Pottern LM; Liff J; Schwartz AG; Fraumeni JF; Hoover RN
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):25-34. PubMed ID: 9950236
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer incidence and tumor severity in Georgia: descriptive epidemiology, racial disparity, and geographic trends.
Wagner SE; Bauer SE; Bayakly AR; Vena JE
Cancer Causes Control; 2013 Jan; 24(1):153-66. PubMed ID: 23179658
[TBL] [Abstract][Full Text] [Related]
13. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
Powell IJ; Schwartz K; Hussain M
Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
[TBL] [Abstract][Full Text] [Related]
14. Black-white differences in the stage at presentation of prostate cancer in the District of Columbia.
Ndubuisi SC; Kofie VY; Andoh JY; Schwartz EM
Urology; 1995 Jul; 46(1):71-7. PubMed ID: 7604479
[TBL] [Abstract][Full Text] [Related]
15. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
Dall'Era MA; deVere-White R; Rodriguez D; Cress R
Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
[TBL] [Abstract][Full Text] [Related]
16. Contemporary risk profile of prostate cancer in the United States.
Shao YH; Demissie K; Shih W; Mehta AR; Stein MN; Roberts CB; Dipaola RS; Lu-Yao GL
J Natl Cancer Inst; 2009 Sep; 101(18):1280-3. PubMed ID: 19713548
[TBL] [Abstract][Full Text] [Related]
17. Stage at presentation and survival of white and black patients with prostate carcinoma.
Brawn PN; Johnson EH; Kuhl DL; Riggs MW; Speights VO; Johnson CF; Pandya PP; Lind ML; Bell NF
Cancer; 1993 Apr; 71(8):2569-73. PubMed ID: 8453581
[TBL] [Abstract][Full Text] [Related]
18. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
[TBL] [Abstract][Full Text] [Related]
19. Demographic differences in prostate cancer incidence and stage: an examination of population diversity in California.
Delfino RJ; Ferrini RL; Taylor TH; Howe S; Anton-Culver H
Am J Prev Med; 1998 Feb; 14(2):96-102. PubMed ID: 9631160
[TBL] [Abstract][Full Text] [Related]
20. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
